|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM353284963 |
003 |
DE-627 |
005 |
20231226055637.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2023 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2023.109272
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1177.xml
|
035 |
|
|
|a (DE-627)NLM353284963
|
035 |
|
|
|a (NLM)36822253
|
035 |
|
|
|a (PII)S1521-6616(23)00051-7
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Yazici, Yusuf
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Difficult-to-treat Behçet syndrome
|b A therapeutic approach
|
264 |
|
1 |
|c 2023
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 04.04.2023
|
500 |
|
|
|a Date Revised 11.04.2023
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2023 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a Behcet syndrome is a systemic vasculitis which can involve many different organ systems. As such, treatment decisions need to be based on organ system involved. In addition, specific patient characteristics potentially predict milder or more severe course, and all these factors need to be taken into consideration when making treatment decisions. In this paper, we review the current approaches to treating Behcet syndrome patients
|
650 |
|
4 |
|a Review
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Azathioprine
|
650 |
|
4 |
|a Behcet syndrome
|
650 |
|
4 |
|a Disease activity
|
650 |
|
4 |
|a Outcomes
|
650 |
|
4 |
|a Personalized medicine
|
700 |
1 |
|
|a Hatemi, Gulen
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 249(2023) vom: 15. Apr., Seite 109272
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:249
|g year:2023
|g day:15
|g month:04
|g pages:109272
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2023.109272
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 249
|j 2023
|b 15
|c 04
|h 109272
|